- Home
- YMM vs NBIX Comparison
YMM vs NBIX Comparison
Compare YMM & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- NBIX
- Stock Information
- Founded
- YMM 2011
- NBIX 1992
- Country
- YMM China
- NBIX United States
- Employees
- YMM N/A
- NBIX N/A
- Industry
- YMM Computer Software: Prepackaged Software
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YMM Technology
- NBIX Health Care
- Exchange
- YMM Nasdaq
- NBIX Nasdaq
- Market Cap
- YMM 12.5B
- NBIX 12.2B
- IPO Year
- YMM 2021
- NBIX 1996
- Fundamental
- Price
- YMM $11.74
- NBIX $126.59
- Analyst Decision
- YMM Buy
- NBIX Strong Buy
- Analyst Count
- YMM 3
- NBIX 20
- Target Price
- YMM $13.00
- NBIX $163.20
- AVG Volume (30 Days)
- YMM 4.8M
- NBIX 857.9K
- Earning Date
- YMM 08-20-2025
- NBIX 07-31-2025
- Dividend Yield
- YMM 1.63%
- NBIX N/A
- EPS Growth
- YMM 55.79
- NBIX N/A
- EPS
- YMM 0.49
- NBIX 2.96
- Revenue
- YMM $1,608,190,451.00
- NBIX $2,412,600,000.00
- Revenue This Year
- YMM N/A
- NBIX $16.29
- Revenue Next Year
- YMM $13.79
- NBIX $15.08
- P/E Ratio
- YMM $24.22
- NBIX $42.60
- Revenue Growth
- YMM 29.63
- NBIX 21.73
- 52 Week Low
- YMM $6.66
- NBIX $84.23
- 52 Week High
- YMM $13.85
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- YMM 46.75
- NBIX 60.49
- Support Level
- YMM $11.51
- NBIX $123.04
- Resistance Level
- YMM $12.67
- NBIX $128.38
- Average True Range (ATR)
- YMM 0.38
- NBIX 2.79
- MACD
- YMM -0.03
- NBIX -0.26
- Stochastic Oscillator
- YMM 17.92
- NBIX 67.50
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.